Here is Why Sutro Biopharma (STRO) is One of the Tiny Stocks That Are On Fire Right Now [Yahoo! Finance]
Sutro Biopharma, Inc. (STRO)
Last sutro biopharma, inc. earnings: 11/8 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
financial results, highlighting a strengthened balance sheet and significant clinical milestones for its antibody-drug conjugate/ADC platform. The company ended 2025 with $141.4 million in cash and marketable securities, which, when combined with a recent $110 million capital raise, extends its cash runway into at least Q2 2028. This financial stability supports a sharpened focus on advancing both wholly owned and partnered oncology programs. A major focus for 2026 is the progress of Sutro's internal pipeline. The company completed dosing for the third cohort in its Phase 1 trial of STRO-004, a potential best-in-class Tissue Factor/TF ADC, with initial clinical data expected in mid-2026. Additionally, Sutro Biopharma Inc. (NASDAQ:STRO) is accelerating the development of STRO-227, its first wholly owned dual-payload program targeting PTK7, with an IND submission now targeted for 2026. The company also expects its ITGB6-targeting ADC, STRO-006, to enter clinical development this year.
Show less
Read more
Impact Snapshot
Event Time:
STRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STRO alerts
High impacting Sutro Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
STRO
News
- Sutro Biopharma (STRO) had its price target raised by Citizens Jmp from $35.00 to $41.00. They now have a "market outperform" rating on the stock.MarketBeat
- Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026GlobeNewswire
- Sutro Biopharma (STRO) had its price target raised by Citizens Jmp from $23.00 to $35.00. They now have a "market outperform" rating on the stock.MarketBeat
- Sutro Biopharma (STRO) had its "outperform" rating reaffirmed by Citigroup Inc..MarketBeat
STRO
Earnings
- 5/8/25 - Miss
STRO
Sec Filings
- 4/22/26 - Form ARS
- 4/22/26 - Form DEFA14A
- 4/22/26 - Form DEF
- STRO's page on the SEC website